Re-evaluation Note REV2015-04, Progress Update on the Pest Management Regulatory Agency-s Re-evaluation Program
Pest Management Regulatory Agency
21 May 2015
ISSN: 1925-0649 (PDF version)
Catalogue number: H113-5/2015-4E-PDF (PDF version)
The purpose of this document is to provide registrants, pesticide regulatory officials and the Canadian public with an update on the status of re-evaluations and special reviews, listed in documents such as Re-evaluation Notes REV2012-13, Update on the Pest Management Regulatory Agency Re-evaluation Initiation Schedule and REV2011-05 Re-evaluation of Pyrethroids, Pyrethrins and Related Active Ingredients. Special reviews of various chemicals are also being conducted. Please see Re-evaluation Notes REV2013-06, Special Review Initiation of 23 Active Ingredients and REV2014-06, Initiation of Special Reviews: Potential environmental risk related to Peponapis pruinosa exposure to Clothianidin, Imidacloprid and Thiamethoxam used on cucurbits.
Health Canada’s Pest Management Regulatory Agency (PMRA) is concurrently engaged in various planned activities for active ingredients (and associated products) within the re-evaluation program, for example, re-evaluation of active ingredients in the current program (such as cyclical re-evaluations, pyrethroids and neonicotinoid pollinator assessment), active ingredients remaining from the previous program (Regulatory Directive DIR2001-03, PMRA Re-evaluation Program) and special reviews, as well as addressing confirmatory studies that were required as a result of previous re-evaluation decisions.
As a result, resources have been prioritized in order to complete certain key documents for each of these activities. This is expected to affect progress on some of the re-evaluations in the current program, as noted below.
PMRA has also published a summary of the re-evaluation work plan for 2015-2018 (REV2015‑05, Pest Management Regulatory Agency Re-evaluation Work Plan 2015-2018). Please refer to that work plan for target years for the re-evaluations or special reviews noted in Tables 1 and 2 as being “in progress”.
Table 1 presents the current re-evaluation status, as of 1 May 2015, for the chemicals listed in re‑evaluation notes REV2012-13 and REV2011-05.
|Chemical Name||Re-evaluation Status|
|4-(2,4-dichlorophenoxy)butyric acid (also known as 2,4 DB)||In progress.|
Project Plan published: Re-evaluation Note REV2013-13.
Project Plan published: Re-evaluation Note REV2013-09.
Project Plan published: Re-evaluation Note REV2013-17.
Project Plan published: Re-evaluation Note REV2013-16.
|D-cis, trans allethrin||In progress.|
|D-trans allethrin||In progress.|
Proposed Re-evaluation Decision in publication process.
|Difenzoquat||Discontinued by the registrant.|
|Dimethomorph||Initiated, Project Plan in publication process.|
|Dimethoxane||Discontinued by the registrant.
Re-evaluation Decision REV2015-01 published 16 February 2015.
Proposed Re-evaluation Decision PRVD2014-02 published 30 April 2014.
|d-phenothrin||Proposed Re-evaluation Decision in publication process.|
Project Plan published: Re-evaluation Note REV2013-08.
|Flumetsulam||Re-evaluation Decision RVD2014-10 published 19 December 2014.
Proposed Re-evaluation Decision PRVD2014-05 published 27 June 2014.
Project Plan published: Re-evaluation Note REV2013-12.
|Fosetyl aluminum||In progress.
Project Plan published: Re-evaluation Note REV2013-14.
|Glyphosate||Proposed Re-evaluation Decision PRVD2015-01 published 13 April 2015. Public consultation period ends 12 June 2015.|
|Imazamox||Proposed Re-evaluation Decision in publications process.|
|Isoxaben||Re-evaluation Decision RVD2014-09 published 10 December 2014.
Proposed Re-evaluation Decision PRVD2014-04 published 20 June 2014.
|Neonicotinoid Pollinator Risk Assessments||In progress.
Re-evaluation Update for Neonicotinoid Insecticides REV2013-15 published 30 December 2013.
|N-octylbicycloheptene dicarboximide||In progress.|
|Nucleopolyhedrovirus for gypsy moth larvae||Re-evaluation Decision RVD2014-07 published 10 December 2014.
Proposed Re-evaluation Decision PRVD2013-02 published 6 November 2013.
Project Plan published: Re-evaluation Note REV2012-15.
|Paclobutrazol||Re-evaluation Decision RVD2014-06 published 16 October 2014.
Proposed Re-evaluation Decision PRVD2013-04 published 15 November 2013.
(and its sodium salt)
|Re-evaluation Decision RVD2014-08 published 10 December 2014.
Proposed Re-evaluation Decision PRVD2013-03 published 6 November 2013.
|Propamocarb||Proposed Re-evaluation Decision in publication process.
Project Plan published: Re-evaluation Note REV2012-16.
|Prosulfuron||Proposed Re-evaluation Decision PRVD2015-02 published 29 April 2015. Public consultation period ends 28 June 2015.|
|Piperonyl butoxide||In progress.|
|Pyridaben||Proposed Re-evaluation Decision in publication process.
Project Plan published: Re-evaluation Note REV2013-10.
Project Plan published: Re-evaluation Note REV2013-11.
|Resmethrin||Discontinued by the registrant.|
|Sodium omadine||In progress.
Project Plan published: Re-evaluation Note REV2012-04.
|Sulfosulfuron||Discontinued by the registrant.|
|Triadimenol||Discontinued by the registrant.|
|Triflusulfuron-methyl||Re-evaluation Decision RVD2015-02 published 23 April 2015.
Proposed Re-evaluation Decision PRVD2014-06 published 27 June 2014.
|(z)-11-tetradecenyl acetate||Discontinued by the registrant.
Re-evaluation Note REV2013-03, Re-evaluation of (z)-11-Tetradecenyl Acetate, published on 24 July 2013.
In addition to the above, re-evaluations of several active ingredients remaining from the previous program (Regulatory Directive DIR2001-03) currently have documents in the publications process. These active ingredients are: chlorothalonil (updated proposed re‑evaluation decision), dimethoate (final re-evaluation decision), methomyl (proposed re‑evaluation decision) and aluminum/magnesium phosphide and phosphine gas (final re‑evaluation decision). Where appropriate, their next steps will be included in the re-evaluation work plan for 2015-2018 (REV2015-05).
Table 2 presents the status, as of 1 May 2015, for the active ingredients (and associated products) currently under special review (see re-evaluation notes REV2013-06 and REV2014-06).
|Chemical Name||Re-evaluation Status|
|Aminopyralid||Special Review Decision REV2014-04 published 28 November 2014.
Proposed Decision REV2014-01 published 24 April 2014.
|Difenoconazole||Special Review Update REV2015-02 published 19 February 2015.|
|Imazapyr||Proposed Special Review Decision REV2014-03 published 28 August 2014. Public consultation step completed.|
|Quintozene||Proposed Special Review Decision REV2014-07 published 18 December 2014. Public consultation step completed.|
Report a problem or mistake on this page
- Date modified: